Angiography | Medical XPRT
Articles & Whitepapers
-
The latest developments of Medis QFR
December 2022 edition Given the regular posts of peer-reviewed scientific publications on the Medis QFR®, it is clear that this angio-based solution for coronary physiology is extensively used in clinical research and practice. We would like to share these publications with you so that you remain up to date about the research that is ongoing worldwide with this innovative solution, ...
-
Exercising Coronary Artery Disease patient - Case study
A cyclo-ergometer exercise test was performed on this 57-year old male patient. He is a smoker with a family background of CAD. He is suffering from left bundle branch block making ST-segment ...
News
-
Ultravist by Bayer now approved for contrast-enhanced mammography in EU
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent ...
Medis QFR continues to show superiority over standard angiography, after a FU-period of 2 years
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer
Arterius Welcomes New Clinical Advisers
Equipment & Solutions
-
Showcase
Contrast Injector
The LeverEdge® Contrast Injector provides a manual operator with complete control. Sterile and disposable, it results in considerable contrast savings. Its patented design injects from .1 to 32 cc of contrast, delivering pressures six times greater(1) than standard syringes.
